Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ENROLLING BY INVITATION
NCT06145139
KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer - an Observational Trial
Sponsor: University of Aarhus
View on ClinicalTrials.gov
Summary
The overall aim of this observational study is to confirm that circulating tumor DNA (ctDNA) detected in plasma and or urine after intended curative treatment for renal cell carcinoma (RCC) can be applied in clinical practice as a marker of subclinical residual disease and risk of recurrence.
Official title: KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
500
Start Date
2023-06-01
Completion Date
2033-06-01
Last Updated
2023-11-22
Healthy Volunteers
No
Conditions
Locations (1)
Urology Department Aarhus University Hospital
Aarhus N, Denmark